News & Information

HFE-Associated Hereditary Hemochromatosis

HFE-associated hereditary hemochromatosis (HFE-HH) is characterized by inappropriately high absorption of iron by the gastrointestinal mucosa. The phenotypic spectrum of HFE-HH is now recognized to include: Those with clinical HFE-HH, in which manifestations of end-organ damage secondary to iron storage are present; Those with biochemical HFE-HH, in which the only evidence of iron overload is […]

June 24, 2016  /  Comments Off on HFE-Associated Hereditary Hemochromatosis

Survey Results

We have posted the results of our survey on phlebotomy costs.  Please click on the link below and them click on the image.  You can enlarge the image by clicking on the expansion arrow in the upper right-hand corner of the image. Thank you for your support. Survey Results Phlebotomy Cost Survey Responses

June 19, 2016  /  Comments Off on Survey Results

First Patient Receives Dose of LJPC-401

PRESS RELEASE SAN DIEGO, Oct 19, 2015 (BUSINESS WIRE) — La Jolla Pharmaceutical Company LJPC, +7.39% (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that the first patient has been dosed in a Phase 1 clinical trial […]

October 20, 2015  /  Comments Off on First Patient Receives Dose of LJPC-401